Literature DB >> 34508546

NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.

Kartik Viswanathan1,2, Shaham Beg1, Bing He1, Taotao Zhang1, Richard Cantley3, Daniel J Lubin4, Qiuying Shi4, Zahra Maleki5, Saeed Asiry6, Rema Rao6, Nora Katabi7, Masato Nakaguro2, William C Faquin2, Peter M Sadow2, Momin T Siddiqui1, Theresa Scognamiglio1.   

Abstract

OBJECTIVES: Salivary gland acinic cell carcinoma (AciCC) has recognizable cytomorphologic features that can overlap with benign and malignant entities, creating a diagnostic challenge. AciCC harbors a t(4;9) translocation increasing nuclear receptor subfamily 4 group A member 3 (NR4A3) expression, detectable by immunohistochemistry (IHC) on surgical resection (SR). NR4A3 IHC cytology data are limited. Here, we examine NR4A3 IHC on smears, cell blocks (CBs), and SRs of AciCC and its mimickers.
METHODS: Our cohort comprised AciCC (including high-grade transformation), secretory carcinoma, mucoepidermoid carcinoma (MEC), Warthin tumor, pleomorphic adenoma (PA), cellular PA, carcinoma ex-PA, oncocytic carcinoma, oncocytoma, and nodular oncocytosis. NR4A3 IHC (Santa Cruz Biotechnology and Origene antibodies) was positive if more than 5% tumor cells showed nuclear staining.
RESULTS: Among CBs, 90% of AciCC cases and none of the mimickers expressed NR4A3. Among SRs, 100% of AciCC cases showed diffuse NR4A3, whereas one high-grade MEC expressed focal NR4A3. Concordance was 95% with two antibody clones. Sensitivity, specificity, positive predictive value, and negative predictive value were 90%, 100%, 100%, and 94.7% for CBs and 100%, 98.8%, 92.3%, and 100% for SRs, respectively. NR4A3 immunostaining was demonstrable on smears from an AciCC case.
CONCLUSIONS: NR4A3 IHC can be a robust diagnostic tool to identify AciCC, especially for cytology specimens. © American Society for Clinical Pathology, 2021. All rights reserved.For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Acinic cell carcinoma; NR4A3; Oncocytic; Salivary

Mesh:

Substances:

Year:  2022        PMID: 34508546      PMCID: PMC8742980          DOI: 10.1093/ajcp/aqab099

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   5.400


  22 in total

1.  A Clinicopathologic Series of 685 Thyroglossal Duct Remnant Cysts.

Authors:  Lester D R Thompson; Hannah B Herrera; Sean K Lau
Journal:  Head Neck Pathol       Date:  2016-05-09

2.  SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.

Authors:  Min-Shu Hsieh; Yi-Hsuan Lee; Yih-Leong Chang
Journal:  Hum Pathol       Date:  2016-06-17       Impact factor: 3.466

3.  Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.

Authors:  Nermine M Abd Raboh; Sarah A Hakim
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.

Authors:  Simon Andreasen; Sushama Varma; Nicholas Barasch; Lester D R Thompson; Markku Miettinen; Lisa Rooper; Edward B Stelow; Tina K Agander; Raja R Seethala; Simion I Chiosea; Preben Homøe; Irene Wessel; Stine R Larsen; Daiva Erentaite; Justin A Bishop; Benedicte P Ulhøi; Katalin Kiss; Linea C Melchior; Jonathan R Pollack; Robert B West
Journal:  Am J Surg Pathol       Date:  2019-04       Impact factor: 6.394

5.  DOG1: a novel marker of salivary acinar and intercalated duct differentiation.

Authors:  Jacinthe Chênevert; Umamaheswar Duvvuri; Simion Chiosea; Sanja Dacic; Kathleen Cieply; Jean Kim; Daniel Shiwarski; Raja R Seethala
Journal:  Mod Pathol       Date:  2012-03-30       Impact factor: 7.842

6.  Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.

Authors:  John M Skaugen; Raja R Seethala; Simion I Chiosea; Michael S Landau
Journal:  Cancer Cytopathol       Date:  2020-08-18       Impact factor: 5.284

7.  Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.

Authors:  Alena Skálová; Radek Sima; Tomas Vanecek; Susan Muller; Marie Korabecna; Jana Nemcova; Goran Elmberger; Ilmo Leivo; Fabricio Passador-Santos; Jiri Walter; Milena Rousarova; Kristina Jedlickova; Romuald Curik; Marie Geierova; Michal Michal
Journal:  Am J Surg Pathol       Date:  2009-08       Impact factor: 6.394

8.  NOR-1 distinguishes acinic cell carcinoma from its mimics on fine-needle aspiration biopsy specimens.

Authors:  Luan Nguyen; Shefali Chopra; Derek B Laskar; Jianyu Rao; David Lieu; Fai Chung; Evelyn D Kim; Mariza de Peralta-Venturina; Shikha Bose; Bonnie Balzer
Journal:  Hum Pathol       Date:  2020-05-19       Impact factor: 3.466

9.  PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms.

Authors:  Ji Hyun Lee; Hye Ju Kang; Chong Woo Yoo; Weon Seo Park; Jun Sun Ryu; Yuh-Seog Jung; Sung Weon Choi; Joo Yong Park; Nayoung Han
Journal:  J Pathol Transl Med       Date:  2018-11-14
View more
  2 in total

Review 1.  [Salivary gland tumors-an overview : Advances in molecular characterization: Part I].

Authors:  Niels J Rupp; Sandra N Freiberger
Journal:  Pathologie (Heidelb)       Date:  2022-10-13

2.  Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.

Authors:  Austin B Wiles; Matthew Gabrielson; Zubair W Baloch; William C Faquin; Vickie Y Jo; Fabiano Callegari; Ivana Kholova; Sharon Song; Barbara A Centeno; Syed Z Ali; Satu Tommola; Guido Fadda; Gianluigi Petrone; He Wang; Esther D Rossi; Liron Pantanowitz; Zahra Maleki
Journal:  Cancer Cytopathol       Date:  2022-04-06       Impact factor: 4.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.